A randomized phase II study evaluating the combination of carboplatin-based chemotherapy with pertuzumab versus carboplatin-based therapy alone in patients with relapsed, platinum-sensitive ovarian cancer (Q87356244)
Jump to navigation
Jump to search
scientific article published on 20 September 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized phase II study evaluating the combination of carboplatin-based chemotherapy with pertuzumab versus carboplatin-based therapy alone in patients with relapsed, platinum-sensitive ovarian cancer |
scientific article published on 20 September 2012 |
Statements
A randomized phase II study evaluating the combination of carboplatin-based chemotherapy with pertuzumab versus carboplatin-based therapy alone in patients with relapsed, platinum-sensitive ovarian cancer (English)
S B Kaye
C J Poole
A Dańska-Bidzińska
G Del Conte
V Gorbunova
E Novikova
A Strauss
M Moczko
V A McNally